These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 6198394
41. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle. Brown WC, Palmer GH, McElwain TF, Hines SA, Dobbelaere DA. Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411 [Abstract] [Full Text] [Related]
42. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions. Steward MW, Sisley BM, Stanley C, Brown SE, Howard CR. Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646 [Abstract] [Full Text] [Related]
43. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV. J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326 [Abstract] [Full Text] [Related]
44. A rabbit helper T cell clone reactive against group-specific streptococcal carbohydrate. Jackson S, Folks TM, Wetterskog DL, Kindt TJ. J Immunol; 1984 Sep 15; 133(3):1553-7. PubMed ID: 6205087 [Abstract] [Full Text] [Related]
45. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens. Couillin I, Pol S, Mancini M, Driss F, Bréchot C, Tiollais P, Michel ML. J Infect Dis; 1999 Jul 15; 180(1):15-26. PubMed ID: 10353856 [Abstract] [Full Text] [Related]
46. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. Meuer SC, Cooper DA, Hodgdon JC, Hussey RE, Morimoto C, Schlossman SF, Reinherz EL. J Immunol; 1983 Sep 15; 131(3):1167-72. PubMed ID: 6309959 [Abstract] [Full Text] [Related]
47. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. Wen WH, Qin WJ, Gao H, Zhao J, Jia LT, Liao QH, Meng YL, Jin BQ, Yao LB, Chen SY, Yang AG. J Viral Hepat; 2007 Jul 15; 14(7):512-9. PubMed ID: 17576393 [Abstract] [Full Text] [Related]
48. [Reciprocal priming-boosting role of HBsAg and DNA vaccines]. Zhou Z, Chen WS, Zhang HH, Yao JL. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 15; 11(4):212-4. PubMed ID: 12716517 [Abstract] [Full Text] [Related]
49. Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine. Nyström J, Cardell K, Björnsdottir TB, Fryden A, Hultgren C, Sällberg M. Vaccine; 2008 Nov 05; 26(47):5967-72. PubMed ID: 18804140 [Abstract] [Full Text] [Related]
51. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL, Gou JJ, Zhang ZY, Jing YX, Zhang L, Guo R, Yan P, Cheng NL, Niu B, Xie J. Hepatobiliary Pancreat Dis Int; 2006 May 05; 5(2):237-41. PubMed ID: 16698583 [Abstract] [Full Text] [Related]
52. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2). Duan XZ, He HX, Zhuang H. J Gastroenterol Hepatol; 2006 Jun 05; 21(6):970-6. PubMed ID: 16724980 [Abstract] [Full Text] [Related]
53. Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination. Sam MR, Shokrgozar MA, Shokri F. Intervirology; 2008 Jun 05; 51(2):87-95. PubMed ID: 18477849 [Abstract] [Full Text] [Related]
54. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. J Immunol; 1995 Jan 15; 154(2):520-9. PubMed ID: 7814865 [Abstract] [Full Text] [Related]
55. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes. Barnaba V, Levrero M, Franco A, Zaccari C, Musca A, Balsano F. J Clin Lab Immunol; 1985 Mar 15; 16(3):137-42. PubMed ID: 3162024 [Abstract] [Full Text] [Related]
56. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Chang TW, Celis E, Miller RW, Zurawski VR, Kung PC. Hepatology; 1984 Mar 15; 4(5):824-9. PubMed ID: 6207089 [Abstract] [Full Text] [Related]
57. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination. Filion LG, Saginur R, Szczerbak N. Clin Exp Immunol; 1988 Mar 15; 71(3):405-9. PubMed ID: 2968200 [Abstract] [Full Text] [Related]
58. Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B. Akbar SM, Furukawa S, Horiike N, Abe M, Hiasa Y, Onji M. J Viral Hepat; 2011 Jun 15; 18(6):408-14. PubMed ID: 20487261 [Abstract] [Full Text] [Related]
59. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders. Suzuki T, Yamauchi K, Kuwata T, Hayashi N. J Gastroenterol Hepatol; 2001 Aug 15; 16(8):898-903. PubMed ID: 11555104 [Abstract] [Full Text] [Related]
60. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. Dusheiko GM, Hoofnagle JH, Cooksley WG, James SP, Jones EA. J Clin Invest; 1983 May 15; 71(5):1104-13. PubMed ID: 6602149 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]